Hormonal Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
Condition:   High Risk Localized Prostate Cancer Intervention:   Sponsor:   Johnson & Johnson Pte Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: RGT-419B;   Drug: RGT-419B in combination with hormonal therapy Sponsor:   Regor Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
Condition:   High Risk Localized Prostate Cancer Intervention:   Sponsor:   Johnson & Johnson Pte Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: RGT-419B;   Drug: RGT-419B in combination with hormonal therapy Sponsor:   Regor Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
Condition:   High Risk Localized Prostate Cancer Intervention:   Sponsor:   Johnson & Johnson Pte Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: RGT-419B;   Drug: RGT-419B in combination with hormonal therapy Sponsor:   Regor Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
Condition:   High Risk Localized Prostate Cancer Intervention:   Sponsor:   Johnson & Johnson Pte Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: RGT-419B;   Drug: RGT-419B in combination with hormonal therapy Sponsor:   Regor Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
Condition:   High Risk Localized Prostate Cancer Intervention:   Sponsor:   Johnson & Johnson Pte Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: RGT-419B;   Drug: RGT-419B in combination with hormonal therapy Sponsor:   Regor Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
Condition:   High Risk Localized Prostate Cancer Intervention:   Sponsor:   Johnson & Johnson Pte Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: RGT-419B;   Drug: RGT-419B in combination with hormonal therapy Sponsor:   Regor Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
Condition:   High Risk Localized Prostate Cancer Intervention:   Sponsor:   Johnson & Johnson Pte Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: RGT-419B;   Drug: RGT-419B in combination with hormonal therapy Sponsor:   Regor Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer
Conditions:   Advanced Breast Cancer;   Hormone Receptor Positive Breast Carcinoma;   HER2-negative Breast Cancer Intervention:   Sponsor:   University of Milano Bicocca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2021 Category: Research Source Type: clinical trials